Single nucleotide polymorphism and expression of P16 gene as a potential biomarker for oral and pre-oral cancer
- PMID: 40591085
- PMCID: PMC12214103
- DOI: 10.1007/s12672-025-03006-z
Single nucleotide polymorphism and expression of P16 gene as a potential biomarker for oral and pre-oral cancer
Abstract
Objective: This study investigated the association between p16 gene and its 450 C > G (rs11515) polymorphism with risk of oral cancer and precancerous oral lesions/oral potentially malignant disorder (OPMD).
Method: The study included 230 individuals with OPMD conditions (70 with leukoplakia, 90 with oral submucous fibrosis, and 70 with lichen planus), 72 oral cancer patients, and 300 cancer-free healthy controls. Genotyping of the p16 450 C > G polymorphism was conducted using PCR-RFLP methods, and genotype and allele frequencies were analyzed using chi-square test. Additionally, p16 gene expression levels were measured using RT-PCR among oral cancer patients, those with OPMD, and healthy controls. RNA fold was used to calculate the MFE of p16 mRNA.
Results: The findings revealed that G allele of p16 450 C > G polymorphism significantly increased risk of oral diseases (oral cancer and OPMD) compared to C allele (OR 1.67, p = 0.0001). GG genotype was associated with higher risk of oral submucous fibrosis (OR 4.63, p = 0.0001), lichenplanus (OR 3.93, p = 0.0002), and leukoplakia (OR 2.38, p = 0.02) compared to CC genotype. Smokers and tobacco chewers carrying the G allele were at a significantly increased risk of developing OPMD (OR = 3.78 and 2.89). Notably, p16 transcript expression was significantly elevated (13.56-fold) in oral cancer patients compared to healthy controls. According to insilco analysis G allele gives more stable transcript of p16 (MEF - 64.90 kcal/mol) compared to C allele (MFE - 61.70 kcal/mol).
Conclusion: These findings suggest that p16 gene and its 450 C > G polymorphism may be associated with risk of oral diseases, indicating their potential utility as biomarkers for these conditions.
Keywords: P16; OPMD; Oral cancer; Polymorphism.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: Ethical approval for this study was obtained from the Ethical Committee of King George’s Medical University, Lucknow named as Institutional Ethics Committee (Registration No: ECR/262/Inst/UP/2013) under approval number 85th ECM II B- Ph.D./P2. This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Consent to participate: Informed consents (Consent to Participate) were obtained from all participants or, if participants are under 18, from a parent and/or legal guardian. Consent for publication: Consent to Publish were obtained from all participants or, if participants are under 18, from a parent and/or legal guardian. All authors have given their consent to publish this work. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Adenosine Triphosphate - Binding Cassette Transporter A1 gene polymorphism (rs1800977 and rs2230806) analysis in Oral Premalignant Disorder of South Indian Cohort.Asian Pac J Cancer Prev. 2025 Mar 1;26(3):1009-1016. doi: 10.31557/APJCP.2025.26.3.1009. Asian Pac J Cancer Prev. 2025. PMID: 40156419 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.Cochrane Database Syst Rev. 2021 Dec 10;12(12):CD010173. doi: 10.1002/14651858.CD010173.pub3. Cochrane Database Syst Rev. 2021. PMID: 34891214 Free PMC article.
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011823. doi: 10.1002/14651858.CD011823.pub2. Cochrane Database Syst Rev. 2017. Retraction in: Cochrane Database Syst Rev. 2021 Nov 30;11:CD011823. doi: 10.1002/14651858.CD011823.pub3. PMID: 28884473 Free PMC article. Retracted.
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
References
-
- National Cancer Institute [Internet]. Surveillance Epidemiology and End Results: SEER Stat Fact Sheets: Oral Cavity and Pharynx - Available from: http://www.seer.cancer.gov/statfacts/html/oralcav.html#incidence-mortality. (2013).
-
- Polanska H, Raudenska M, Gumulec J, et al. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol. 2014;50:168–77. - PubMed
-
- Ghalwash DM. Diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer: review Article. J Oral Maxillofac Surg Med Pathol. 2020;32(6):538–43.
Grants and funding
LinkOut - more resources
Full Text Sources